Almost ten million people in Germany have an eye disease that can potentially cause vision loss, such as age-related macular degeneration (AMD). Future prognosis show that these numbers will continue to rise as the population ages, for example by 15% for AMD by 2050 (1). On average, about 80% of all sensory experiences in humans are based on vision, and the special importance of vision as compared to other senses and diseases has been shown in various international studies.
We conducted a representative survey in order to understand the importance of such a widespread health challenge as the deterioration of vision and the factors that influence this perception in the German population.
Acknowledgments
Translated from the original German by Veronica A. Raker, PhD.
Footnotes
Conflict of interest statement The Stiftung Auge (Eye Foundation) of the Deutschen Ophthalmologischen Gesellschaft (DOG) provided funding for the project.
Prof. Terheyden has received project support through the provision of equipment from Heidelberg Engineering, Optos, Carl Zeiss Meditec, and CenterVue.
Prof. Schuster is holder of an endowed professorship from the Stiftung Auge and has received financial support from the DOG and the Berufsverband der Augenärzte Deutschlands e.V.
Prof. Holz is a board member of DOG, an executive board member of Euretina, member of the Scientific and Medical Advisory Board of Pro Retina Deutschland.
The remaining authors declare that no conflict of interest exists.
Methods
From October 2020 to February 2021, data including sociodemographic information were collected as part of an ongoing representative population telephone survey (Kantar Health Germany) according to the guidelines of the Working Group of German Market and Social Research Institutes (Arbeitskreis Deutscher Markt- und Forschungsinstitute) (2). The main questions asked were about (see Table 1):
Table 1. Survey results.
All respondents | ||
Total | 10 869 | |
Question 1: Presence of visual impairment, n (%) | ||
− No visual impairment − Some visual impairment − Major visual impairment − I cannot see at all − No response |
8034 (73.9) 2161(19.9) 408 (3.8) 50 (0.5) 216 (2.0) |
|
All respondents | Respondents with visual impairment | |
Total, n (%) | 10 869 | 2619 (24.1 %) |
Question 2: Most feared health problem, n (%) | ||
− Stroke (e.g. with hemiplegia)− Cancer − Dementia − Blindness − Deafness − Loss of an arm or leg − HIV/AIDS − None of these health problems − Not sure / no response |
1913 (17.6) 2766 (25.4) 2602 (23.9) 1169 (10.8) 51 (0.5) 228 (2.1) 96 (0.9) 1067 (9.8) 977 (9.0) |
457 (17.4) 681 (25.7) 609 (24.7) 416 (15.9) 12 (0.5) 55 (2.1) 28 (1.1) 181 (6.9) 180 (6.9) |
Total, n (%) | 10 868 | 2618 |
Question 3: Most feared sensory loss, n (%) | ||
− Blindness − Muteness − Deafness − Loss of balance − Loss of smell or taste − Not sure − No response |
7326 (67.4) 334 (3.1) 739 (6.8) 1025 (9.4) 420 (3.9) 527 (4.9) 497 (4.6) |
1780 (68.0) 97 (3.7) 219 (8.4) 236 (9.0) 112 (4.3) 101 (3.9) 73 (2.8) |
the participant’s visual impairments;
the participant’s assessment of blindness with respect to other serious diseases; and
the participant’s assessment of blindness with respect to other sensory losses.
The target group was the German-speaking population aged ≥ 40 years in Germany. The data were evaluated descriptively and by means of regression analysis.
Results
A total of 10 869 participants were surveyed. About a quarter of the participants (24.1%) reported visual impairment despite wearing glasses or contact lenses (table 1). The more visual impairment were reported, the older the participants were (p <0.001) and the lower the household income was (2% visual impairment at <3500 €/month, and 7.7% at <1500 €/month; p <0.001).
In a multivariable ordinal regression model, a lower likelihood of reporting visual impairment was associated with living in a multi-person household (odds ratio [OR]: 0.81; 95% confidence interval [0.72; 0.91]), being male (OR: 0.80; CI [0.73; 0.88]), being employed (OR: 0.84; CI [0.73; 0.97]), and having a higher educational qualification (OR: 0.85; CI [0.76; 0.96]).
The most feared health problems were cancer (25.4%), dementia (23.9%), stroke (17.6%), and blindness (10.8%). In households with an income of < 1 500 Euros, the fear of blindness was highest, at 19.8% (p <0.01). Similar to dementia and stroke, blindness was feared by older participants and by people living in single-person households or who reported visual impairment (p <0.01).
In the multi-variable, multinomial regression model, visual impairment was associated with a higher probability of reporting blindness as the most feared condition as compared to stroke, cancer, or dementia (table 2). A below-average household income also increased the probability of blindness being perceived to be the most feared disease with respect to cancer or dementia. Living in a multi-person household, on the other hand, reduced that probability.
Table 2. Dreaded diseases: associations in a multinomial regression model with the reference category blindness*1.
Stroke | Cancer | Dementia | Deafness | Loss of a limb | AIDS/HIV | No fears | |
Odds ratio [95% confidence interval] | |||||||
Visual impairment*2 | 0.56*3 [0.50; 0.71] |
0.66*3 [0.56; 0.78] |
0.55*3 [0.46; 0.65] |
0.67 [0.33; 1.04] |
0.83 [0.58; 1.19] |
0.74 [0.45; 1.24] |
0.40*3 [0.32; 0.50] |
Gender: male | 1.14 [0.97; 1.33] |
0.77*3 [0.66; 0.90] |
0.83*3 [0.71; 0.97] |
0.85 [0.46; 1.56] |
1.45*3 [1.04; 2.01] |
1.32 [0.83; 2.09] |
1.40*3 [1.15; 1.70] |
University entrance qualification*2 | 1.00 [0.82; 1.23] |
1.04 [0.86; 1.25] |
1.30*3 [1.08; 1.57] |
1.45 [0.74; 2.84] |
0.79 [0.53; 1.19] |
1.13 [0.65; 1.97] |
1.23 [0.65; 1.97] |
Net household income <2500 euro*2 | 0.88 [0.73; 1.07] |
0.74*3 [0.62; 0.89] |
0.60*3 [0.50; 0.72] |
0.75 [0.36; 1.56] |
0.87 [0.59; 1.28] |
1.44 [0.84; 2.46] |
0.95 [0.75; 1.19] |
Employed*2 | 1.47*3 [1.16; 1.88] |
1.05 [0.84; 1.32] |
1.01 [0.80; 1.27] |
1.67 [0.64; 4.35] |
1.57 [0.95; 2.61] |
0.35*3 [0.19; 0.65] |
0.85 [0.63; 1.29] |
Multi-person household*2 | 1.48*3 [1.16; 1.88] |
2.32*3 [1.92; 2.80] |
1.59*3 [1.32; 1.91] |
1.95 [0.85; 4.49] |
1.51 [1.00; 2.70] |
2.49*3 [1.38; 4.49] |
1.30*3 [1.04; 1.63] |
Additional year of life (age) | 1.03*3 [1.02; 1.03] |
0.98*3 [0.98; 0.99] |
1.02*3 [1.01; 1.03] |
1.00 [0.96; 1.05] |
0.98 [0.96; 1.00] |
0.94*3 [0.91; 0.96] |
1.01*3 [1.00; 1.02] |
n = 7957 (at least one entry was missing for 2912 of these)
Odds ratio <1 indicates that if this characteristic is present (for instance, visual impairment), the respective disease (for instance, stroke) is feared less than blindness.
*1 Reference category blindness (Nagelkerke r2 = 0.099);
*2 Dichotomized independent variables;
*3 p <0.05
In the survey, blindness was by far the most feared sensory loss, at 67.4% (table 1). People who were older, had completed only elementary or secondary school, were not employed, lived in a single-person household, or were men were more likely to fear blindness more than any other sensory loss (p <0.001).
Discussion
In this representative population survey, almost 70% of the participants rated blindness as the worst possible sensory loss. The diseases that were the most feared were severe stroke, cancer, and dementia, followed by blindness, whereby the latter was rated as the most serious illness by every tenth respondent. Thus, good vision and the corresponding fear of vision loss are of considerable importance in the health perception of a large part of the German population aged ≥ 40 years.
Our study shows for the first time that in Germany, visual impairments are more common among respondents with low household incomes than in the population as a whole.
This confirms results from various industrialized countries that have reported blindness and visual impairment to be inversely related to higher incomes (3). This reflects, among other things, that vision loss requires significant support—financial and/or family. For example, informal support from family members is the most important resource for the blind and partially sighted in Germany (4).
The strengths of our study include its representativeness and large sample as well as the collection of socio-demographic data that have either not been collected or only sparsely collected in comparable studies. The limitations of the study include the pre-given response options, a certain bias due to self-selection by the participants, and the lack of objectification of the reported visual impairments. However, the latter is unproblematic, as self-reported visual impairments correlate very well with objectifiable functional impairments (5).
In summary, the study impressively shows that, for the general population, vision and visual health are very important. Given the rapid increase in age-related eye diseases that can potentially impair vision, this importance should be reflected in health and science policy agendas.
References
- 1.Li JQ, Welchowski T, Schmid M, Mauschitz MM, Holz FG, Finger RP. Prevalence and incidence of age-related macular degeneration in Europe: a systematic review and meta-analysis. Br J Ophthalmol. 2020;104:1077–1084. doi: 10.1136/bjophthalmol-2019-314422. [DOI] [PubMed] [Google Scholar]
- 2.Arbeitskreis Deutscher Markt- und Forschungsinstitute. ADM Dual Frame Projekt - Forschungsbericht. www.adm-ev.de/leistungen/forschungsprojekte/ (last accessed on 21 January 2022) [Google Scholar]
- 3.Ulldemolins AR, van Lansingh C, Valencia LG, Carter MJ, Eckert KA. Social inequalities in blindness and visual impairment: a review of social determinants. Indian J Ophthalmol. 2012;60:368–375. doi: 10.4103/0301-4738.100529. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Chuvarayan Y, Finger RP, Köberlein-Neu J. Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study. Eur J Health Econ. 2020;21:115–127. doi: 10.1007/s10198-019-01115-5. [DOI] [PubMed] [Google Scholar]
- 5.Köberlein-Neu J, Seifert A, Himmelsbach I. Selbstberichtetes Sehvermögen in der (gerontologischen) Versorgungsforschung und -praxis - ein Plädoyer zur Öffnung. Ophthalmologe. 2018;115:818–825. doi: 10.1007/s00347-018-0704-2. [DOI] [PubMed] [Google Scholar]